Esc 2015: Assessing Risk Of Bleeding In Patients Who Require New Oral Anticoagulants

ESC 2015: Assessing risk of bleeding in patients who require new oral anticoagulants

ESC 2015: Assessing risk of bleeding in patients who require NOACs-Prof Martinez-Rubio

ESC 2015: Anticoagulants in atrial fibrillation: Identifying high risk patients

Anticoagulation and risk of bleeding with Atrial Fibrillation

American Heart Association

Bleeding in patients receiving DOACs-121661

Dove Medical Press

Managing Bleeding Events in Patients Receiving Direct Oral Anticoagulants

Novel oral anticoagulants: Risk score for major bleeding

International Pharmaceutical Federation

Predicting High Risk of Bleeding - Phil Wells

Predicting Risk of Bleeding in Medical Patients

Direct-acting oral anticoagulants (DOACs): bleeding risk and reversal agents

Updates in Anticoagulation 2015 video

EHRA free webinar: Use of oral anticoagulants in AF patients undergoing cardioversion

European Society of Cardiology

Dabigatran and Bleeding Risks in Older Patients

Critical Pathways for the Assessment of Anticoagulants in the Bleeding Patient

NAThrombosisForum

Webinar - Bleeding Risk on Anticoagulation Meds with Prof Kerstin de Wit

Thrombosis Ireland

Clot Chronicles: Updated Guidance on Managing Bleeding in Patients on Oral Anticoagulation

NAThrombosisForum

Real-world Data: Post-marketing Assessment of Major Bleeding with Rivaroxaban

An Ounce of Prevention: Strategies for Safe Anticoagulation in Vulnerable Patients

NAThrombosisForum

Performance of oral anticoagulants in high risk patient populations with atrial fibrillation

European Society of Cardiology